Characterizing Rare Disease Biology in Clinical Studies to Observe Drug Effects in Patient Sub-Populations

Time: 11:00 am
day: Day One


  • Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses
  • Using unsupervised computerized AI analysis to assess large data
  • Correlating genomic analysis with extensive clinical data outcomes and endpoint scales